NRSN NRSN
Company Profile ↓Company Overview
NRSN (NRSN) is a publicly traded company listed on with a market capitalization of $17.58M. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Growth & Price Performance
Stock Price Performance
| 1 Year: | -57.00% |
| 6 Months: | -41.11% |
| 3 Months: | -42.97% |
| 1 Month: | -23.47% |
- Price vs 50-DMABelow
- Price vs 200-DMABelow
- RSI (14)36.26 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
No notable strengths flagged.
CONS
- Trading 60.7% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Dec 2024 |
|---|---|
| Revenue | 0 |
| Cost of Revenue | - |
| Gross Profit | - |
| Operating Expenses | 1.77M |
| Operating Income | -1.77M |
| EBITDA | -1.77M |
| Interest Expense | - |
| Pretax Income | -1.80M |
| Tax Provision | - |
| Net Income | -1.80M |
| Diluted EPS | - |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Revenue | - | 0 | 0 | 0 | 0 |
| Cost of Revenue | - | - | - | - | - |
| Gross Profit | - | - | - | - | - |
| Operating Expenses | - | 10.55M | 12.05M | 9.90M | 11.09M |
| Operating Income | - | -10.55M | -12.05M | -9.90M | -11.09M |
| EBITDA | - | -10.54M | -12.03M | -9.88M | -11.07M |
| Interest Expense | 0 | 15.00K | 11.00K | - | - |
| Pretax Income | - | -10.49M | -10.11M | -10.21M | -11.12M |
| Tax Provision | - | - | - | - | - |
| Net Income | - | -10.49M | -10.11M | -10.21M | -11.12M |
| Diluted EPS | - | -0.91 | -0.74 | -0.54 | -0.44 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Total Assets | - | 7.71M | 3.19M | 4.58M | 1.03M |
| Current Assets | - | 7.38M | 2.92M | 4.40M | 778.00K |
| Cash & Equivalents | - | 3.54M | 2.64M | 3.38M | 166.00K |
| Inventory | - | - | - | - | - |
| Receivables | - | 131.00K | 166.00K | 164.00K | 33.00K |
| Total Liabilities | - | 2.09M | 4.94M | 1.99M | 2.59M |
| Current Liabilities | - | 1.73M | 3.46M | 1.99M | 2.52M |
| Long Term Debt | - | - | - | - | - |
| Total Debt | - | 211.00K | 142.00K | 73.00K | 170.00K |
| Total Equity | - | 5.62M | -1.76M | 2.58M | -1.56M |
| Shares Outstanding | - | 11.78M | 15.38M | 23.23M | 32.56M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | -7.62M | -8.35M | -10.13M | -7.67M |
| Investing Cash Flow | - | -3.59M | 3.47M | 1.00K | -8.00K |
| Financing Cash Flow | - | 3.77M | 3.98M | 10.91M | 4.43M |
| Capital Expenditure | - | -70.00K | -29.00K | -3.00K | -8.00K |
| Free Cash Flow | - | -7.69M | -8.38M | -10.14M | -7.68M |
| Net Change in Cash | - | -7.43M | -911.00K | 779.00K | -3.25M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Gross Margin % | - | - | - | - | - |
| Operating Margin % | - | - | - | - | - |
| Net Margin % | - | - | - | - | - |
| ROE % | - | -186.7% | 574.6% | -395.3% | 713.1% |
| ROCE % | - | -176.4% | 4,397.4% | -383.4% | 745.0% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for NRSN
NeuroSense Therapeutics Ltd. SEC Filing (Aug 3, 2026) - Stock Titan
<a href="https://news.google.com/rss/articles/CBMirAFBVV95cUxNaXpEcXc5QTQtTnRtOGQwVEhzUlMzMlZCYV9JbllaZi12MFNpMjJLMHdlM3liUWxSYXpscWJRekhoRzNVNFg5REJfV1JYZ1M3T1hfQVRoeExPd1B3R0hjenp2eXRRX3pjVVhRam1nQkhscjluNGI0VHdQVkdyR3lRcExqRjlUMG01WkxGOX…
NRSN Forecast — Price Target — Prediction for 2027 - TradingView
<a href="https://news.google.com/rss/articles/CBMiekFVX3lxTFBnM2hnb1BtMGJIREMyUkF4aE5NcHRfSG9za19heW5zSnU3TGZBRVZqRGktVFJtckJpRkVDSFVKZFlxcExmVDZzMVB3ODhCY3M3YmVOdGs5TDItbXpfTk9IMTZHVm9QMXRKTTVrRk91eC1mV05hZ3A0eEVn?oc=5" target="_blank">NRS…
$NRSN stock is down 8% today. Here's what we see in our data. - Quiver Quantitative
<a href="https://news.google.com/rss/articles/CBMimwFBVV95cUxNWHYyZGstcnlIcktQQ0lBd291b0lFNjhqaEhDMmpUc2k0OEllaUJ4Y1F4VGVIUmFzaGMwRGQtOW9tVmoyU0JrVW5HZGk5YndNV2d0UXJzRzZ5Uk1BWk9RV1FBbW52V08zMzJWdm5EaS1tR0NHSFZvNGtYUHB1NTlRblJ1VVBwMlhsWHdZXz…
NeuroSense Therapeutics Announces Receipt of Nasdaq Notifications Regarding Minimum Bid Price and Market Value Requirements - PR Newswire
<a href="https://news.google.com/rss/articles/CBMiiwJBVV95cUxPcTRVZmhaTllxQ1F1dGRHelJaYnZ4VTNod3JCVWpqUEhSNF9IbGpJdFZDNlEtWm01NU1TLXA4Xy1XRlVuZk9tQ1EzSDl3NUhwYnZrdnhzSTFHMGo0MDhKU0FzUzlKc2dkeGJqaVlINGo4TnFLc01KYUlWanpaeTU5cWhGbmVDTW8xeFUxQU…
NeuroSense Therapeutics (NRSN) revises Capital on Demand share sales deal - Stock Titan
<a href="https://news.google.com/rss/articles/CBMiwgFBVV95cUxPcTRGUENRWGdzSlotSUZIajFTeFRENVZXdl9JakhMQUNzSHRzYnhzLXJ5MkNNc1d6M1FBUnlnWDRPcmtfUXBCaWRRcl8wNHhrNzlLdDI0X3U5YTFzSW01Z1NUTFNRbVlyTjN1MXRGM1Z5eUMxNW85cy1RWlA3dDR1d1JocHBXUDJMc09Vai…
NRSN|Neurosense Therapeutics Ltd|Price:0.465|Chg%:-0.011 - TradingKey
<a href="https://news.google.com/rss/articles/CBMibkFVX3lxTFA1OWhteUk0YnNkcVJQdEJqV1p6QUR1WEhLbUtBRHpxbjVhMFB1RURxQndqYWJwNHR5NmV1YjEyYmRaWEhQSEZYejFMOU5RYnVvbk9BVkRJNnNnVlQ4eGlqVzlhcE1RZ25ocFZmUm53?oc=5" target="_blank">NRSN|Neurosense The…
NRSN — Frequently Asked Questions
What is the current share price of NRSN?
As of 2026-08-05 17:25 PDT, NRSN trades at $0.54 on NASDAQ/NYSE. Its 52-week range is $0.46 to $1.38.
What is the market capitalisation of NRSN?
NRSN has a market capitalisation of $17.58M on NASDAQ/NYSE.
What is the P/E ratio of NRSN?
NRSN trades at a trailing price-to-earnings (P/E) ratio of -1.23. Its price-to-book (P/B) ratio is -11.27.
Is NRSN a good stock to buy?
This page provides a data-driven analysis of NRSN, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.